GlaxoSmithKline | 당기 순이익

주가
2,182.50
매일 변경
2.50 0.11%
매월
14.78%
매년
51.25%
Q1 예상
1,839.16




당기 순이익 변화 날짜
AbbVie USD 1.82B 1.63B 2025-12
Alcon AG USD 237M 61M 2025-09
Almirall EUR 26.58M 31.82M 2025-06
Amgen USD 1.33B 1.88B 2025-12
argenx SE USD 344.26M 98.9M 2025-09
AstraZeneca USD 2.53B 83M 2025-09
Bayer EUR -963M 764M 2025-09
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Fresenius EUR 344M 14M 2025-09
Fresenius Medical Care EUR 274.8M 49.8M 2025-09
Galapagos EUR -202.11M 96.36M 2025-09
Genmab DKK 336M 141M 2025-06
Gilead Sciences USD 3.05B 1.09B 2025-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
GRIFOLS EUR 126.96M 9.9M 2025-09
Hikma Pharmaceutical USD 119M 14M 2025-06
Lonza CHF 307M 22M 2024-12
Merck EUR 902M 250M 2025-09
Merck USD 2.96B 2.82B 2025-12
Novartis USD 3.93B 96M 2025-09
Novo Nordisk DKK 26.89B 388M 2025-12
Orion EUR 96M 13.5M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Philips EUR 184M 56M 2025-09
Recordati EUR 110.16M 19.08M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Smith & Nephew USD 293M 79M 2025-12
UCB EUR 857M 649M 2024-12


GlaxoSmithKline 당기 순이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.